Knowledge Track
Essential Science. Curated for You.
In today’s rapidly advancing field of cardiovascular medicine, timely access to evidence and expert insight is essential. Knowledge Tracks are an ESC initiative created to strengthen awareness and accelerate the dissemination of science on key topics that matter for clinicians and patients worldwide. Each Track curates a focused selection of congress presentations, trial updates, and expert discussions, chosen to highlight the most relevant developments for practice and education. Knowledge Tracks on ESC 365 extend access to this curated knowledge, ensuring that every member of the cardiovascular community can stay informed, understand evolving evidence, and apply insights that improve practice and patient care.
Because when knowledge is shared, lives are changed.
Hypertrophic cardiomyopathy (HCM) is a complex genetic disease with challenges in diagnosis, risk stratification, and treatment. This Track gathers congress presentations, trial updates, imaging insights, and therapeutic debates to give you a clear view of current advances in HCM.
Supported by Bristol Myers Squibb
Lipoprotein(a) [Lp(a)] is a genetically determined lipid particle and independent risk factor for cardiovascular disease and aortic valve stenosis. This Track curates resources on epidemiology, clinical insights, testing, and therapies to raise awareness and support informed practice.
Supported by Novartis
